facebook linkedin twitter
Pfizer CEO Talks Vaccine Equity, Booster Needs, and Enhancements
Health
Pfizer CEO Talks Vaccine Equity, Booster Needs, and Enhancements
2021-05-19 20:40:32
by Kate Michael

WASHINGTON — Recent studies conducted by Pfizer-BioNTech and results of a follow-up to Phase III trials confirmed that protection against COVID-19 stays high — over 91% — for at least six months after receiving two doses of the Pfizer vaccine.... Read More

Straight From The Well
scroll top